Erenumab For Treatment of Hemicrania Continua

Clinical trial NCT04303845 · TERMINATED

Trial details

NCT number: NCT04303845
Sponsor: Mayo Clinic
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Hemicrania Continua

Start date: 2021-08-04
Primary completion: 2022-04-06
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.